Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
Aligos Therapeutics (ALGS) Ownership - Who Owns Aligos Therapeutics?
78 Followers
Aligos Therapeutics (ALGS) Ownership Overview
38.02% Insiders
2.05% Mutual Funds
6.43% Other Institutional Investors
53.51% Public Companies and
Individual Investors
The ownership structure of Aligos Therapeutics (ALGS) stock is a mix of institutional, retail and individual investors. Approximately 8.47% of the company’s stock is owned by Institutional Investors, 38.02% is owned by Insiders and 53.51% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 27, 2023 | Carole Nuechterlein Director | Bought | $5950201 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,320,381 | Institution | 3.20% | 1,814,538 | |
| 2,076,400 | Institution | 2.86% | 1,623,745 | |
| 988,471 | Institution | 1.36% | 772,984 | |
| 987,055 | Institution | 1.36% | 771,877 | |
| 321,922 | Institution | 0.44% | 251,743 | |
| 92,000 | Institution | 0.13% | 71,944 | |
| 70,656 | Institution | 0.10% | 55,253 | |
| 31,383 | Institution | 0.04% | 24,542 | |
| 24,596 | Institution | 0.03% | 19,234 | |
| 21,969 | Institution | 0.03% | 17,180 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 987,055 | Institution | 1.36% | 771,877 | |
| 321,922 | Institution | 0.44% | 251,743 | |
| 92,000 | Institution | 0.13% | 71,944 | |
| 31,383 | Institution | 0.04% | 24,542 | |
| 24,596 | Institution | 0.03% | 19,234 | |
| 21,969 | Institution | 0.03% | 17,180 | |
| 6,179 | Institution | <0.01% | 4,832 | |
| 162 | Institution | <0.01% | 127 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 712,990 | Institution | 0.98% | 698,730 | |
| 275,481 | Institution | 0.38% | 269,971 | |
| 70,656 | Institution | 0.10% | 58,192 | |
| 125 | Institution | <0.01% | 114 |
FAQ
Who Owns Aligos Therapeutics (ALGS)?
According to the latest TipRanks data, approximately 6.43% of the company's stock is held by institutional investors, 38.02% is held by insiders, and 53.51% is held by retail investors.
What percentage of Aligos Therapeutics (ALGS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.43% of Aligos Therapeutics (ALGS) stock is held by institutional investors.
What percentage of Aligos Therapeutics (ALGS) stock is held by retail investors?
According to the latest TipRanks data, approximately 53.51% of Aligos Therapeutics (ALGS) stock is held by retail investors.
Who owns the most shares of Aligos Therapeutics (ALGS)?
Brad Bolzon owns the most shares of Aligos Therapeutics (ALGS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.